Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.
Stork L, Brück W, von Gottberg P, Pulkowski U, Kirsten F, Glatzel M, Rauer S, Scheibe F, Radbruch H, Hammer E, Stürner KH, Kaulen B, Heesen C, Hoffmann F, Brock S, Pawlitzki M, Bopp T, Metz I. Stork L, et al. Among authors: pawlitzki m. Mult Scler. 2019 Oct;25(12):1618-1632. doi: 10.1177/1352458518819098. Epub 2019 Jan 18. Mult Scler. 2019. PMID: 30657420
ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.
Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M, Mawrin C, Rommer P, Kovacs GG, Mitter C, Reindl M, Brück W, Wandinger KP, Lassmann H, Höftberger R, Leypoldt F. Körtvélyessy P, et al. Among authors: pawlitzki m. Neurol Neuroimmunol Neuroinflamm. 2017 Mar 14;4(3):e335. doi: 10.1212/NXI.0000000000000335. eCollection 2017 May. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28331892 Free PMC article. No abstract available.
High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients.
Schneider-Hohendorf T, Schulte-Mecklenbeck A, Ostkamp P, Janoschka C, Pawlitzki M, Luessi F, Zipp F, Meuth SG, Klotz L, Wiendl H, Gross CC, Schwab N. Schneider-Hohendorf T, et al. Among authors: pawlitzki m. Mult Scler. 2021 Sep;27(10):1491-1496. doi: 10.1177/1352458520970103. Epub 2020 Nov 5. Mult Scler. 2021. PMID: 33150829 Free PMC article.
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.
Rolfes L, Pawlitzki M, Pfeuffer S, Nelke C, Lux A, Pul R, Kleinschnitz C, Kleinschnitz K, Rogall R, Pape K, Bittner S, Zipp F, Warnke C, Goereci Y, Schroeter M, Ingwersen J, Aktas O, Klotz L, Ruck T, Wiendl H, Meuth SG. Rolfes L, et al. Among authors: pawlitzki m. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 14;8(5):e1035. doi: 10.1212/NXI.0000000000001035. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34261812 Free PMC article.
Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study.
Rolfes L, Pfeuffer S, Huntemann N, Schmidt M, Su C, Skuljec J, Aslan D, Hackert J, Kleinschnitz K, Hagenacker T, Pawlitzki M, Ruck T, Kleinschnitz C, Meuth SG, Pul R. Rolfes L, et al. Among authors: pawlitzki m. Mult Scler Relat Disord. 2022 Aug;64:103931. doi: 10.1016/j.msard.2022.103931. Epub 2022 May 29. Mult Scler Relat Disord. 2022. PMID: 35690010 Free article.
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies.
Masanneck L, Rolfes L, Regner-Nelke L, Willison A, Räuber S, Steffen F, Bittner S, Zipp F, Albrecht P, Ruck T, Hartung HP, Meuth SG, Pawlitzki M. Masanneck L, et al. Among authors: pawlitzki m. Mult Scler Relat Disord. 2022 Jul;63:103927. doi: 10.1016/j.msard.2022.103927. Epub 2022 May 28. Mult Scler Relat Disord. 2022. PMID: 35700670 Free article.
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, Havla J, Hellwig K, Hümmert MW, Jarius S, Kleiter I, Klotz L, Krumbholz M, Paul F, Ringelstein M, Ruprecht K, Senel M, Stellmann JP, Bergh FT, Trebst C, Tumani H, Warnke C, Wildemann B, Berthele A; Neuromyelitis Optica Study Group (NEMOS). Kümpfel T, et al. J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7. J Neurol. 2024. PMID: 37676297 Free PMC article. Review.
89 results